New nasal methicillin-resistant Staphylococcus aureus colonization during hospitalization in children: a prospective observational study from Iran
This prospective observational study from Iran found that 6.1% of hospitalized children acquired new nasal MRSA colonization, a risk significantly associated with female sex, underlying diseases, sulfonamide and corticosteroid exposure, and specific clinical units, though the findings are limited by a small sample size and require further validation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the human nose, a tiny ecosystem often exists where bacteria live without causing harm. Among these residents is Staphylococcus aureus, a common germ that most people carry without issue. However, a specific version of this bacterium, known as methicillin-resistant Staphylococcus aureus or MRSA, has developed the ability to survive treatments that usually kill it. When this resistant germ takes up residence in the nose, it acts as a hidden reservoir. While the person may feel fine, the bacteria can spread to others in a hospital or, worse, move from the nose to a wound or the lungs, causing a serious infection that is difficult to treat. For children admitted to the hospital, understanding when and how they pick up this resistant germ is vital for keeping them safe and preventing outbreaks.
Researchers in Tehran, Iran, set out to map this risk by watching children closely during their hospital stays. They focused on a specific question: how often do children who arrive at the hospital without MRSA in their noses acquire it while they are there? To find the answer, the team worked at Mofid Children's Hospital, enrolling young patients across five different departments, including surgery, infectious diseases, and the intensive care unit. They began by taking a gentle swab from the noses of every eligible child within the first two days of their admission to establish a baseline. If a child tested negative for MRSA at the start, the researchers returned to swab them again at discharge or every ten days if their stay was long. This method allowed the team to distinguish between germs a child brought from home and those they picked up inside the hospital.
The study followed 164 children who completed the full process of screening at the start and again at the end of their stay. Among this group, ten children developed new nasal colonization with MRSA during their hospitalization. This means that roughly six out of every hundred children in the study acquired the resistant bacteria after arriving. On average, it took about eight days from admission for the bacteria to be detected in these children. The researchers found that the risk was not spread evenly; it was concentrated in specific groups. Eight of the ten children who acquired the infection had an underlying chronic illness, with half of them battling cancer. The remaining children with new colonization also had serious conditions, such as immune system disorders or liver disease.
Certain factors appeared to increase the likelihood of picking up the germ. The study observed that girls were significantly more likely to acquire MRSA than boys in this specific group. The type of hospital ward also mattered, with the hematology unit showing a higher rate of new cases. Medical treatments played a role as well. Children who received sulfonamide antibiotics, a specific class of drugs used to treat bacterial infections, were more likely to acquire MRSA. Similarly, those treated with corticosteroids, medicines used to reduce inflammation and suppress the immune system, faced a higher risk. The use of a nasogastric tube, a flexible tube passed through the nose into the stomach to deliver food or medicine, showed a trend toward association with the infection, though the evidence for this was not as strong as for the other factors.
When the researchers analyzed the bacteria they found, they discovered a clear pattern of resistance. Every single strain of MRSA acquired in the hospital was resistant to penicillin and common macrolide antibiotics like erythromycin and azithromycin. However, the bacteria remained vulnerable to two other drugs, linezolid and rifampin, which could be used if treatment became necessary. Importantly, none of the new hospital-acquired strains carried the Panton–Valentine leukocidin gene. This gene is often found in community strains of MRSA and is associated with severe skin and lung infections, suggesting that the hospital strains in this study were different from those circulating outside the hospital walls.
The authors of the study emphasize that while these findings offer valuable clues, they must be viewed with caution. The number of children who acquired the infection was small, which makes it difficult to draw definitive conclusions about cause and effect. The wide range of uncertainty around some of the statistics, particularly regarding the higher risk for girls, suggests that these results are a starting point for further investigation rather than a final answer. The researchers also noted that their study was limited to a single hospital over a short period, and some children were excluded because they left before a final sample could be taken. Despite these limitations, the work provides a clear picture of the timeline and the specific vulnerabilities of hospitalized children, highlighting that those with serious underlying illnesses, particularly cancer, require careful monitoring to prevent the silent spread of resistant bacteria.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.